Dianthus Therapeutics (DNTH) Misses Q1 EPS by 54c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q1 EPS of ($0.54). Revenue for the quarter came in at $870 thousand.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Nomura/Instinet Downgrades RHB Bank (RHBBANK:MK) to Neutral
• BofA sees mixed signals for European software from US SaaS